Prescribing Update Newsletter – May 2024

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact

This month’s edition focuses on recent RDTC publications and the dates of our upcoming demo and Q&A sessions on RDTC reports, publications, and resources.

View the preview below on desktop, or click here to download a copy.

RDTC at Clinical Pharmacy Congress North

We’re pleased to confirm that RDTC will be at the inaugural CPC North this November!

The event takes place in Manchester on November 3rd and 4th. More details are available on the Pharmacy Congress website, and registration is still open.

You can find us at stand A23, where we’ll be ready to chat about our work and what we can do for you. We’ll have examples of recent work to show how we can support your medicines optimisation and strategic activities, together with what we have planned for the upcoming year.

Monica Mason, Head of Prescribing Support at the RDTC, will be joining the Chairs of GMMMG Professor Charlotte Skitterall and Claire Vaughan at 9:30am on Friday morning in the Clinical Theatre in a session titled “Optimisation of medicines opportunities in Greater Manchester”. Find full details on the CPC North Programme.

We look forward to seeing you there!

Budget impact of methylphenidate modified release tablet choice

The latest in the RDTC’s prescribing bulletin series covers methylphenidate, and highlights the difference in cost between bioequivalent methylphenidate modified release (MR) tablets. It considers the budget impact of MR tablet choice and shows the yearly primary care spend on all methylphenidate XL tablets, and the proportion of this spend on each of the available brands.

This bulletin, and our others, are available from the Prescribing Bulletins page.

Monthly formulary amendments – March 2023

A Monthly Formulary Amendments document covering guidance and alerts published in March 2023 is now available.

The purpose of the document is to support consistent decision making by APCs. This information is produced for use by NHS healthcare professionals and RDTC stakeholders.

This document is available alongside previous editions on the formulary amendments page.